Newsroom

News

The Helmholtz Centre for Infection Research (HZI) is once again coordinating an international research and exchange project in fungal research through “Mycobiomics 2.0”. The recently launched project is funded as a Marie Skłodowska-Curie Action (MSCA) under the EU’s Horizon Europe research framework program and has a total budget of nearly 1.8 million euros. Mycobiomics 2.0 builds on the successful predecessor projects “GoMyTri” (2014–2018) and “Mycobiomics” (2021–2025), which were also coordinated by the HZI. The project focuses on the discovery of new anti-infective compounds to combat the increasing spread of antimicrobial resistance.

18.09.2026

HZI Campus

HIPS

News

On September 17, 2026, the grand opening of the first expansion building of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) took place on the campus of Saarland University. As part of the event, the groundbreaking ceremony for a second expansion building also occurred, with completion planned for 2029. Together with the existing building, the two new buildings are intended to provide space for up to 350 researchers to discover and develop new active ingredients to combat infectious diseases and beyond. The effective area of the two new buildings totals 6,000 m², distributed across laboratory, office, and seminar spaces. The construction projects are being funded with a total of 89.5 million euros, with 20 million provided by the federal government and the remaining funding coming from the state of Saarland and the European Union. The launch of this unprecedented expansion process at a Helmholtz Institute was an expansion resolution passed by the Budget Committee of the Bundestag in December 2020. HIPS is a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University.

17.09.2026

HIPS

Flock of sheep in warm morning light on a pasture.

News

A highly contagious viral disease, sheeppox spreads rapidly and can affect large portions of a flock in a short time. The disease is particularly dangerous because it can cause very high mortality rates, especially in young animals, and dramatically reduces productivity by damaging wool, meat and milk yields. By extracting DNA from a range of ancient animal remains, an international team of geneticists, historians, virologists, protein chemists and conservators, has been able to uncover more than 3,500 years of history of the sheeppox virus (SPPV). The Helmholtz Institute for One Health (HIOH), a site of the Helmholtz Centre for Infection Research (HZI), took part to the study led by University College Dublin (UCD).

08.09.2026

HIOH

News

For its cross-regional collaboration, the DEEP-DV research consortium (“Disrupt – Evade – Exploit: Gene expression and manipulation of the host response in DNA virus infections”) has been awarded the 2026 North German Science Prize. The consortium, jointly headed by Prof. Nicole Fischer (University Medical Centre Hamburg-Eppendorf (UKE)) and Prof. Melanie Brinkmann (Technische Universität Braunschweig and Helmholtz Centre for Infection Research (HZI)), is investigating how DNA viruses evade the immune system and remain in the body permanently. Since 2012, the federal states of Bremen, Hamburg, Mecklenburg-Western Pomerania, Lower Saxony and Schleswig-Holstein have used this prize to recognize cooperation projects across a range of disciplines; this year’s award focuses on the life sciences. Three projects were honored, each receiving prize money of 83,333 euros.

04.09.2026

HZI Campus

News

Pseudomonas aeruginosa is a rod-shaped, Gram-negative bacterium capable of infecting various parts of the body, including the lungs, skin, and bloodstream. It accounts for approximately 7 per cent of hospital-acquired infections worldwide and is linked to around 559,000 deaths annually. Researchers from the group of Prof. Michael Kolbe at the Centre for Structural System Biology (CSSB), along with collaborators from Research Center Jülich, EMBL Hamburg, DESY and BIOTECH Thailand have uncovered novel virulence mechanisms of phospholipase C from P. aeruginosa. Their findings are published in Protein & Cell and shed new light on how this pathogen evades host defenses and causes severe disease. The CSSB is a common initiative by nine northern German research institutions, including the Helmholtz Centre for Infection Research (HZI) in Braunschweig.

03.09.2026

CSSB

Scientist working with an analytical instrument in the laboratory.

News

Antimicrobial resistance is one of the greatest challenges facing modern medicine. A new class of programmable antibiotics known as asobiotics can be used to treat bacterial infections when classical antibiotics fail. A team of researchers from TWINCORE, Centre for Experimental and Clinical Infection Research, the RESIST Cluster of Excellence and from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg has now studied, how bacteria adapt to asobiotics. They recently published their finding in Nature Communications. TWINCORE and HIRI are sites of the Helmholtz Centre for Infection Research (HZI) in cooperation with Hannover Medical School and Julius-Maximilians-Universität Würzburg, respectively.

31.08.2026

TWINCORE

HIRI

HZI in the media

... die klinische Validität. Ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) hat mit „Metax“ nun einen ...

02.10.2026

Analytik.de

Mikrobiologen auch Kolleg*innen vom IST Austria und dem HZI in Braunschweig gehören: Inhibitoren von Aktin unterbinden diese dynamischen

01.10.2026

Science.apa.at

... der Medizinischen Hochschule Hannover sowie am Helmholtz-Zentrum für Infektionsforschung tätig ist. Als Co-Autor ist zudem ...

30.09.2026

Ad Hoc News

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

30.09.2026

Phys.org

for cell movement. Scientists from the Helmholtz Center for Infection Research (HZI) in Braunschweig have provided evidence that Profilin

29.09.2026

TakeToNews

Biology (BRICS), a joint research center of the Helmholtz Centre for Infection Research (HZI) and Technische Universität Braunschweig.

29.09.2026

Phys.org

... treffsicher .

Das Helmholtz-Zentrum für Infektionsforschung:

Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) ...

28.09.2026

DeutschesGesundheitsPortal

... Fluorchinolon-Resistenz aktiv

Forscher des Helmholtz-Zentrums für Infektionsforschung (HZI) um Dr. Jennifer Herrmann haben ...

27.09.2026

scinexx - Das Wissensmagazin

Die WHO nennt Antibiotikaresistenzen (AMR) eine der größten globalen Gesundheitsbedrohungen. Bereits heute töten resistente Keime jährlich mehr als eine Million Menschen direkt und tragen zu fast fünf Millionen Todesfällen bei. Tendenz: steigend. Für ein wirkungsvolles Dagegenha

25.09.2026

Sysmex

... die Resistenzen": HZI-Podcast InFact mit Mark Brönstrup

Quelle: Helmholtz-Zentrum für Infektionsforschung (HZI)

Biodiversität ...

25.09.2026

Analytik NEWS

Quelle: Pressemitteilung

Helmholtz-Zentrum für Infektionsforschung

24.09.2026

LaborPraxis

Lange galt Dopamin als simples Glückshormon. Alena Buyx zeigt in ihrer Sendung, dass der Botenstoff ...

24.09.2026

3sat

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.